Marko Klobučar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marko Klobučar has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Sandra Kraljević Pavelić
Faculty of Health Studies, University of Rijeka, 51000 Rijeka, Croatia
8 shared publications - Krešimir Pavelić
Faculty of Medicine, Juraj Dobrila University of Pula, Zagrebačka 30, 52100 Pula, Croatia
5 shared publications - Mirela Sedić
Centre for Applied Bioanthropology, Institute for Anthropological Research, Ljudevita Gaja 32, 10000 Zagreb, Croatia
5 shared publications Lana Kovač-Bilić
University Department of ENT, Head and Neck Surgery, Kišpatićeva 12, 10 000 Zagreb, Croatia
2 shared publicationsMario Bilić
University Department of ENT, Head and Neck Surgery, Kišpatićeva 12, 10 000 Zagreb, Croatia
2 shared publicationsPeter Gehrig
Functional Genomics Center Zürich, University of Zurich/ETH Zurich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland
2 shared publications
Latest Publications
- Open Access
- 31 July 2026
- Published by Croatian Natural History Museum in Natura Croatica
- Vol. 35 (1) , 215-224
Three reptile species newly recorded in Učka Nature Park (Croatia)
Učka Nature Park in northeastern Istria represents an important habitat for herpetofauna, yet knowledge of certain reptile occurrences within the park has been limited. Field surveys conducted in 2024 and 2025 at selected peripheral sites confirmed, for the first time, the presence of three reptile species previously undocumented in the park: the four-lined snake Elaphe quatuorlineata Lacepède, 1789, European glass lizard Pseudopus apodus (Pallas 1775), and Mediterranean house gecko Hemidactylus turcicus (Linnaeus, 1758). These findings expand the known reptile fauna of Učka Nature Park and provide a valuable baseline for future research, monitoring, and conservation efforts.
- 31 July 2026
- Published by Croatian Natural History Museum in Natura Croatica
- Vol. 35 (1) , 215-224
Open AccessThree reptile species newly recorded in Učka Nature Park (Croatia)
Učka Nature Park in northeastern Istria represents an important habitat for herpetofauna, yet knowledge of certain reptile occurrences within the park has been limited. Field surveys conducted in 2024 and 2025 at selected peripheral sites confirmed, for the first time, the presence of three reptile species previously undocumented in the park: the four-lined snake Elaphe quatuorlineata Lacepède, 1789, European glass lizard Pseudopus apodus (Pallas 1775), and Mediterranean house gecko Hemidactylus turcicus (Linnaeus, 1758). These findings expand the known reptile fauna of Učka Nature Park and provide a valuable baseline for future research, monitoring, and conservation efforts.
- 1 September 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 503 (2) , 843-848
Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK−mediated signalling
- 1 September 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 503 (2) , 843-848
Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK−mediated signalling
- 22 August 2017
- Published by Wiley in Electrophoresis
- Vol. 38 (22-23) , 2909-2913
Affinity chromatography on monolithic supports for simultaneous and high‐throughput isolation of immunoglobulins from human serum
Posttranslational modifications of immunoglobulins have been a topic of great interest and have been repeatedly reported as a major factor in disease pathology. Cost‐effective, reproducible, and high‐throughput (HTP) isolation of immunoglobulins from human serum is vital for studying the changes in protein structure and the following understanding of disease development. Although there are many methods for the isolation of specific immunoglobulin classes, only a few of them are applicable for isolation of all subtypes and variants. Here, we present the development of a scheme for fast and simultaneous affinity purification of α (A), γ (G), and μ (M) immunoglobulins from human serum through affinity monolith chromatography. Affinity‐based monolithic columns with immobilized protein A, G, or L were used for antibody isolation. Monolithic stationary phases have a high surface accessibility of binding sites, large flow‐through channels, and can be operated at high flow rates, making them the ideal supports for HTP isolation of biopolymers. The presented method can be used for HTP screening of human serum in order to simultaneously isolate all three above‐mentioned immunoglobulins and determine their concentration and changes in their glycosylation pattern as potential prognostic and diagnostic disease biomarkers.
- 22 August 2017
- Published by Wiley in Electrophoresis
- Vol. 38 (22-23) , 2909-2913
Affinity chromatography on monolithic supports for simultaneous and high‐throughput isolation of immunoglobulins from human serum
Posttranslational modifications of immunoglobulins have been a topic of great interest and have been repeatedly reported as a major factor in disease pathology. Cost‐effective, reproducible, and high‐throughput (HTP) isolation of immunoglobulins from human serum is vital for studying the changes in protein structure and the following understanding of disease development. Although there are many methods for the isolation of specific immunoglobulin classes, only a few of them are applicable for isolation of all subtypes and variants. Here, we present the development of a scheme for fast and simultaneous affinity purification of α (A), γ (G), and μ (M) immunoglobulins from human serum through affinity monolith chromatography. Affinity‐based monolithic columns with immobilized protein A, G, or L were used for antibody isolation. Monolithic stationary phases have a high surface accessibility of binding sites, large flow‐through channels, and can be operated at high flow rates, making them the ideal supports for HTP isolation of biopolymers. The presented method can be used for HTP screening of human serum in order to simultaneously isolate all three above‐mentioned immunoglobulins and determine their concentration and changes in their glycosylation pattern as potential prognostic and diagnostic disease biomarkers.
- Open Access
- 4 August 2017
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 22 (2) , 1071-1082
Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential
Objectives The aim of this study was to examine molecular alterations on the protein level in lesions of oral lichen planus (OLP), oral squamous cell carcinoma (OSCC) and healthy mucosa. Materials and methods Global protein profiling methods based on liquid chromatography coupled to mass spectrometry (LC-MS) were used, with a special emphasis on evaluation of deregulated extracellular matrix molecules expression, as well as on analyses of IG2F and IGFR2 expression in healthy mucosa, OLP and OSCC tissues by comparative semi-quantitative immunohistochemistry. Results Mass spectrometry-based proteomics profiling of healthy mucosa, OLP and OSCC tissues (and accompanied histologically unaltered tissues, respectively) identified 55 extracellular matrix proteins. Twenty among identified proteins were common to all groups of samples. Expression of small leucine-rich extracellular matrix proteoglycans lumican and biglycan was found both in OSCC and OLP and they were validated by Western blot analysis as putative biomarkers. A significant increase (p < 0.05) of biglycan expression in OLP-AT group was determined in comparison with OLP-T group, while lumican showed significant up-regulation (p < 0.05) in OLP-T and OSCC-T groups vs. adjacent and control tissue groups. Biglycan expression was only determined in OSCC-AT group. Immunohistochemical analysis of IGF2 and IG2FR expression revealed no significant difference among groups of samples. Conclusion/clinical relevance Biglycan and lumican were identified as important pathogenesis biomarkers of OLP that point to its malignant potential.
- 4 August 2017
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 22 (2) , 1071-1082
Open AccessExpression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential
Objectives The aim of this study was to examine molecular alterations on the protein level in lesions of oral lichen planus (OLP), oral squamous cell carcinoma (OSCC) and healthy mucosa. Materials and methods Global protein profiling methods based on liquid chromatography coupled to mass spectrometry (LC-MS) were used, with a special emphasis on evaluation of deregulated extracellular matrix molecules expression, as well as on analyses of IG2F and IGFR2 expression in healthy mucosa, OLP and OSCC tissues by comparative semi-quantitative immunohistochemistry. Results Mass spectrometry-based proteomics profiling of healthy mucosa, OLP and OSCC tissues (and accompanied histologically unaltered tissues, respectively) identified 55 extracellular matrix proteins. Twenty among identified proteins were common to all groups of samples. Expression of small leucine-rich extracellular matrix proteoglycans lumican and biglycan was found both in OSCC and OLP and they were validated by Western blot analysis as putative biomarkers. A significant increase (p < 0.05) of biglycan expression in OLP-AT group was determined in comparison with OLP-T group, while lumican showed significant up-regulation (p < 0.05) in OLP-T and OSCC-T groups vs. adjacent and control tissue groups. Biglycan expression was only determined in OSCC-AT group. Immunohistochemical analysis of IGF2 and IG2FR expression revealed no significant difference among groups of samples. Conclusion/clinical relevance Biglycan and lumican were identified as important pathogenesis biomarkers of OLP that point to its malignant potential.
- 1 March 2017
- Published by Elsevier in Life Sciences
- Vol. 173, 73-79
Expression of polysialic acid in primary laryngeal squamous cell carcinoma
- 1 March 2017
- Published by Elsevier in Life Sciences
- Vol. 173, 73-79
Expression of polysialic acid in primary laryngeal squamous cell carcinoma
- 1 October 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1862 (10) , 1938-1954
Basement membrane protein ladinin-1 and the MIF-CD44-β1 integrin signaling axis are implicated in laryngeal cancer metastasis
- 1 October 2016
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1862 (10) , 1938-1954
Basement membrane protein ladinin-1 and the MIF-CD44-β1 integrin signaling axis are implicated in laryngeal cancer metastasis
- 12 October 2015
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 6 (11) , 1150-1155
Discovery of New Acid Ceramidase-Targeted Acyclic 5-Alkynyl and 5-Heteroaryl Uracil Nucleosides
A series of novel N-acyclic uracil analogs with linear, branched, aromatic, and cyclopropyl-alkynyl as well as heteroaryl moieties at C-5 were prepared using palladium catalyzed Sonogashira and Stille cross-coupling and evaluated against malignant tumor cell lines. C-5-Furan-2-yl uracil derivative 6 was shown to be more potent against MCF-7 than the reference drug 5-fluorouracil (5-FU), while C-5-alkynyl uracil derivatives 9c and 9e exhibited antibreast cancer activities comparable to 5-FU. Selected compounds induced cell death, partially due to apoptosis, of MCF-7 breast cancer cells. Abrogation of acid ceramidase (ASAH1) expression of 9c and 9e indicated that these compounds could perturb ASAH1-mediated sphingolipid signaling. The selective activity of 9c and 9e against breast cancer cells via the ASAH1-mediated signaling, as a molecular target, might have a great advantage for potential future therapeutic use.
- 12 October 2015
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 6 (11) , 1150-1155
Discovery of New Acid Ceramidase-Targeted Acyclic 5-Alkynyl and 5-Heteroaryl Uracil Nucleosides
A series of novel N-acyclic uracil analogs with linear, branched, aromatic, and cyclopropyl-alkynyl as well as heteroaryl moieties at C-5 were prepared using palladium catalyzed Sonogashira and Stille cross-coupling and evaluated against malignant tumor cell lines. C-5-Furan-2-yl uracil derivative 6 was shown to be more potent against MCF-7 than the reference drug 5-fluorouracil (5-FU), while C-5-alkynyl uracil derivatives 9c and 9e exhibited antibreast cancer activities comparable to 5-FU. Selected compounds induced cell death, partially due to apoptosis, of MCF-7 breast cancer cells. Abrogation of acid ceramidase (ASAH1) expression of 9c and 9e indicated that these compounds could perturb ASAH1-mediated sphingolipid signaling. The selective activity of 9c and 9e against breast cancer cells via the ASAH1-mediated signaling, as a molecular target, might have a great advantage for potential future therapeutic use.
- 1 September 2015
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1852 (9) , 1833-1845
UV-induced retinal proteome changes in the rat model of age-related macular degeneration
- 1 September 2015
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1852 (9) , 1833-1845
UV-induced retinal proteome changes in the rat model of age-related macular degeneration
- Open Access
Novel Coumarin Derivatives Containing 1,2,4-Triazole, 4,5-Dicyanoimidazole and Purine Moieties: Synthesis and Evaluation of Their Cytostatic Activity
We report here on the synthesis and in vitro anti-tumor effects of a series of novel 1,2,4-triazole (compounds 3–6), 4,5-dicyanoimidazole (compound 7), and purine (compounds 8–13) coumarin derivatives and their acyclic nucleoside analogues 14–18. Structures of novel compounds 3–18 were deduced from their 1H- and 13C-NMR and corresponding mass spectra. Results of anti-proliferative assays performed on a panel of selected human tumor cell lines revealed that compound 6 had moderate cytostatic activity against the HeLa cell line (IC50 = 35 µM), whereas compound 10 showed moderate activity against the HeLa (IC50 = 33 µM), HepG2 (IC50 = 25 µM) and SW620 (IC50 = 35 µM) cell lines. These compounds showed no cytotoxic effects on normal (diploid) human fibroblasts.
Open AccessNovel Coumarin Derivatives Containing 1,2,4-Triazole, 4,5-Dicyanoimidazole and Purine Moieties: Synthesis and Evaluation of Their Cytostatic Activity
We report here on the synthesis and in vitro anti-tumor effects of a series of novel 1,2,4-triazole (compounds 3–6), 4,5-dicyanoimidazole (compound 7), and purine (compounds 8–13) coumarin derivatives and their acyclic nucleoside analogues 14–18. Structures of novel compounds 3–18 were deduced from their 1H- and 13C-NMR and corresponding mass spectra. Results of anti-proliferative assays performed on a panel of selected human tumor cell lines revealed that compound 6 had moderate cytostatic activity against the HeLa cell line (IC50 = 35 µM), whereas compound 10 showed moderate activity against the HeLa (IC50 = 33 µM), HepG2 (IC50 = 25 µM) and SW620 (IC50 = 35 µM) cell lines. These compounds showed no cytotoxic effects on normal (diploid) human fibroblasts.